MARKET

BEIGF

BEIGF

Beigene
OTCPK
19.78
NaN%
Closed 09:30 03/18 EDT
OPEN
--
PREV CLOSE
19.78
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
19.78
52 WEEK LOW
11.00
MARKET CAP
25.37B
P/E (TTM)
-28.7709
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BEIGF last week (0310-0314)?
Weekly Report · 1d ago
Tracking Baker Brothers Portfolio - Q4 2024 Update
Seeking Alpha · 5d ago
Weekly Report: what happened at BEIGF last week (0303-0307)?
Weekly Report · 03/10 10:31
Weekly Report: what happened at BEIGF last week (0224-0228)?
Weekly Report · 03/03 10:31
Weekly Report: what happened at BEIGF last week (0217-0221)?
Weekly Report · 02/24 10:31
Weekly Report: what happened at BEIGF last week (0210-0214)?
Weekly Report · 02/17 10:29
Weekly Report: what happened at BEIGF last week (0203-0207)?
Weekly Report · 02/10 10:25
Weekly Report: what happened at BEIGF last week (0127-0131)?
Weekly Report · 02/03 10:28
More
About BEIGF
BeiGene, Ltd. is a global biotechnology company engaged in discovering and developing oncology treatments for cancer patients worldwide. The Company has discovered and developed three approved medicines, including BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of various blood cancers; TEVIMBRA (tislelizumab), an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and pamiparib, a selective small molecule inhibitor of poly ADP-ribose polymerase 1 (PARP1) and PARP2. The Company has obtained approvals to market BRUKINSA in the United States, the People's Republic of China (China or the PRC), the European Union, the United Kingdom, Canada, Australia, and additional international markets; tislelizumab in the European Union and China; and pamiparib in China. It also focuses on commercializing cancer medicines, such as XGEVA, BLINCYTO, KYPROLIS, and others in China under an exclusive license from Amgen Inc.

Webull offers Beigene Ltd stock information, including OTCPK: BEIGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BEIGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BEIGF stock methods without spending real money on the virtual paper trading platform.